0.8244
price up icon5.26%   0.0412
after-market Handel nachbörslich: .85 0.0256 +3.11%
loading

Bioatla Inc Aktie (BCAB) Neueste Nachrichten

pulisher
Dec 08, 2025

Taking on analysts’ expectations and winning: BioAtla Inc (BCAB) - setenews.com

Dec 08, 2025
pulisher
Dec 04, 2025

Is BioAtla Inc. stock positioned well for digital economyTrade Risk Report & Safe Entry Trade Signal Reports - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Will BioAtla Inc. stock continue dividend increasesJuly 2025 Levels & Stepwise Entry and Exit Trade Signals - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Why BioAtla Inc. stock is considered a top pickDollar Strength & High Return Trade Opportunity Guides - Newser

Dec 03, 2025
pulisher
Nov 30, 2025

Biotech Momentum Builds In After-Hours Trading As BioAtla, Entero, And Sonnet Climb - Nasdaq

Nov 30, 2025
pulisher
Nov 26, 2025

Can BioAtla Inc. stock rebound after recent weaknessMarket Rally & Low Risk Growth Stock Ideas - moha.gov.vn

Nov 26, 2025
pulisher
Nov 25, 2025

BioAtla, Inc. (BCAB) -11.3% in Intraday Trading: What’s Driving the Move? - Stocks Telegraph

Nov 25, 2025
pulisher
Nov 24, 2025

BioAtla Inc. (BCAB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 24, 2025
pulisher
Nov 24, 2025

The growth track for BioAtla Inc (BCAB) has changed recently - setenews.com

Nov 24, 2025
pulisher
Nov 24, 2025

[PRE 14A] BioAtla, Inc. Preliminary Proxy Statement - Stock Titan

Nov 24, 2025
pulisher
Nov 21, 2025

BioAtla Reports Q3 2025 Financial Results and Progress - MSN

Nov 21, 2025
pulisher
Nov 21, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Nov 21, 2025
pulisher
Nov 21, 2025

Form 424B5 BioAtla, Inc. - StreetInsider

Nov 21, 2025
pulisher
Nov 21, 2025

[424B5] BioAtla, Inc. Prospectus Supplement (Debt Securities) - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

BioAtla Secures $7.5 Million Pre-Paid Advance - TipRanks

Nov 21, 2025
pulisher
Nov 21, 2025

[8-K] BioAtla, Inc. Reports Material Event | BCAB SEC FilingForm 8-K - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

BioAtla’s New Funding: A Double-Edged Sword for Shareholders - Ad-hoc-news.de

Nov 21, 2025
pulisher
Nov 21, 2025

BioAtla Agrees to $22.5 Million in Financing Agreements - MarketScreener

Nov 21, 2025
pulisher
Nov 21, 2025

BioAtla Enters into Agreements for up to $22.5 Million Flexible Financing - Investing News Network

Nov 21, 2025
pulisher
Nov 21, 2025

BioAtla, Inc. Secures $7.5 Million Financing to Support Operations During Strategic Partnership Negotiations - Quiver Quantitative

Nov 21, 2025
pulisher
Nov 21, 2025

BioAtla Enters into Agreements for up to $22.5 Million Flexible Financing - GlobeNewswire Inc.

Nov 21, 2025
pulisher
Nov 20, 2025

Is BioAtla Inc (BCAB) Good For Your Portfolio? - fostersleader.com

Nov 20, 2025
pulisher
Nov 19, 2025

Regression analysis insights on BioAtla Inc. performanceWeekly Trend Summary & AI Enhanced Market Trend Forecasts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What catalysts could drive BioAtla Inc. stock higherProfit Target & Fast Gain Swing Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Measuring BioAtla Inc.’s beta against major indicesTrade Analysis Report & Community Consensus Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Ewing Sarcoma Market Research Report 2025-2035: Salarius, Eli Lilly, Pfizer, and BioAtla Lead by Driving Innovations in the Development of Novel Targeted Therapies - Yahoo Finance

Nov 19, 2025
pulisher
Nov 18, 2025

BioAtla Inc. stock outlook for YEAR2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Bioatla Shares Surge on Strong Clinical and Financial Results - Ad-hoc-news.de

Nov 18, 2025
pulisher
Nov 17, 2025

Sentiment analysis tools applied to BioAtla Inc.Take Profit & Verified Momentum Watchlists - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

What moving averages say about BioAtla Inc.Portfolio Return Summary & Accurate Entry/Exit Alerts - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

BioAtla Inc (BCAB) can make a big difference with a little luck - Setenews

Nov 17, 2025
pulisher
Nov 17, 2025

BioAtla outlines $800M peak sales target for Oz-V as FDA alignment paves way for phase III launch - MSN

Nov 17, 2025
pulisher
Nov 16, 2025

Analyzing BioAtla Inc. with multi timeframe chartsMarket Sentiment Report & High Accuracy Swing Entry Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Analyzing BioAtla Inc. with risk reward ratio chartsTrade Performance Summary & Weekly Watchlist of Top Performers - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

BioAtla, Inc.Common Stock (Nasdaq:BCAB) Stock Quote - Markets Financial Content

Nov 16, 2025
pulisher
Nov 15, 2025

What to do if you’re stuck in BioAtla Inc.Sell Signal & Reliable Price Action Trade Plans - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Chart overlay techniques for tracking BioAtla Inc.July 2025 Sentiment & Technical Confirmation Alerts - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Is BioAtla Inc. a candidate for recovery playGap Down & AI Powered Trade Plan Recommendations - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

BioAtla Tightens Belt But Analysts Remain Upbeat - Finimize

Nov 14, 2025
pulisher
Nov 14, 2025

BioAtla, Inc. (NASDAQ:BCAB) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 14, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):